Skip to main content
. 2016 Mar 19;7(16):22857–22864. doi: 10.18632/oncotarget.8213

Table 4. Univariate and multivariate survival analysis of the patients with lung adenocarcinoma (n = 335).

Mean Survival (months) Univariate analysis Multivariate Analysis
HR 95% CI p value HR 95% CI p value
Age < 65 vs ≥ 65 59.0 vs 58.0 0.87 0.55~1.36 0.538 1.20 0.76~1.88 0.429
Gender female vs male 63.0 vs 55.0 1.71 1.12~2.61 0.013 2.04 1.24~3.35 0.005
Smoking No vs Yes 59.5 vs 56.2 0.98 0.62~1.57 0.947 0.69 0.40~1.17 0.384
Stage < 0.0001 < 0.0001
 I 69.1 (Reference)
 II 54.8 3.03 1.41~6.51
 III 56.5 3.95 1.96~7.98
 IV 31.4 8.76 3.86~19.9
Total mutation ≤ 4 vs > 4 61.0 vs 48.4 2.19 1.13~4.24 0.020 1.81 1.05~3.13 0.034